Improving speech treatment for children with apraxia
ASSIST: Child Apraxia Speech Treatment
This study is looking for ways to help young children with childhood apraxia of speech (CAS) improve their ability to speak clearly, using a promising treatment method called integral stimulation, so they can communicate better and enjoy a better quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10600110 on NIH RePORTER |
What this research studies
This research focuses on childhood apraxia of speech (CAS), a condition that affects children's ability to plan and execute the movements necessary for clear speech. The project aims to develop and test effective treatment methods, particularly an approach called integral stimulation, which has shown promise in previous studies. By addressing the limitations of current therapies and optimizing treatment strategies, the research seeks to enhance communication skills and overall quality of life for affected children. The study will involve children under 11 years old who struggle with speech due to CAS, and it will utilize rigorous methodologies to ensure reliable results.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years diagnosed with childhood apraxia of speech.
Not a fit: Children who do not have apraxia or those with other unrelated speech disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective speech therapies that significantly improve communication abilities in children with apraxia.
How similar studies have performed: Previous research has shown some success with similar treatment approaches, but this study aims to expand the evidence base and improve treatment efficacy.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Maas, Edwin — Temple Univ of the Commonwealth
- Study coordinator: Maas, Edwin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.